I’d strongly disagree they will be unprofitable. Zoleo JV aside selling 10,000 Iridium Go will be big. The JV will have big subscription revenue for 2022. The marketing is in remote areas, it will not be prime time CBD slot prices. I’d think JV will absorb the costs and will hardly notice it.
I’d strongly disagree they will be unprofitable. Zoleo JV aside...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.015(8.82%) |
Mkt cap ! $13.39M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 16.0¢ | 14.0¢ | $8.719K | 56.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 44352 | 1 |
View Market Depth
| Last trade - 15.53pm 30/08/2024 (20 minute delay) ? |
| BCC (ASX) Chart |